The International Association of Athletics Federations (IAAF) has been informed by the Fédération Française d’Athlétisme (FFA) that the male athlete, Nordine Gezzar, has been found guilty of the following doping violation under IAAF Rules:
Presence of the prohibited substances Finasteride (S5. Diuretics and Other Masking Agents) and Norandrosterone (S1. Anabolic Agents) in his doping control sample (IAAF Rule 32.2a)
This doping violation relates to a samples collected in-competition on 19.06.06 and 22.07.06
In conformity with the IAAF Rules, the FFA has imposed the following sanction for a first violation:
• 2 years ineligibility (15.12.06 – 14.12.08)
• Disqualification of all results from 19.06.06
This information has been added to the 2006 List of Anti-doping Rule Violations which can be found on the IAAF website in the anti-doping statistics section.
Note: Under the IAAF Rules, athletes sanctioned for a doping violation have the right to appeal this decision to the relevant appeals body.
“The IAAF is committed to protecting the sport of athletics from the threat of doping. Each year the IAAF spends more than 2.5 million dollars on this ongoing battle and coordinates approximately 3,000 doping controls. All IAAF out-of-competition tests are conducted on a strictly no-advance-notice basis.